Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,754 public trials 592 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Recruiting

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

NCT03715933

Conditions
Colorectal Adenocarcinoma, Ewing Sarcoma, Neoplasms, +7 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Precision NextGen Oncology and Research Beverly Hills, California, United States
  • City of Hope Duarte, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 37 locations
View Trial Details
Recruiting

Anti-GD2 ADC M3554 in Advanced Solid Tumors

NCT06641908

Conditions
Advanced Solid Tumor, Astrocytoma, Glioblastoma, +10 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - Memorial Sloan Kettering Cancer Center (CC)- Westc New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • UZ Leuven Leuven, Belgium
View Trial Details
Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 29 locations
View Trial Details
Recruiting

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NCT06422806

Conditions
Histiocytoma, Histiocytoma, Malignant Fibrous, Liposarcoma, +13 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 257 locations
View Trial Details
Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

NCT05732831

Conditions
Adenocarcinoma, Adenoma, Carcinoma, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Grand Valley Oncology Grand Junction, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 26 locations
View Trial Details

Related conditions